Furthermore, a recent study showed that FHL2 interacts with TGF-β1 and inhibits its expression (Dahan et al., 2017) and is involved in kidney fibrosis (Duan et al., 2020), liver fibrosis (Huss et al., 2013), and lung fibrosis (Alnajar et al., 2013). The gene discussed is FHL2; the disease is Hepatic fibrosis.